Breaking News Instant updates and real-time market news.

SNY

Sanofi

$39.19

(0.00%)

, REGN

Regeneron

$321.78

1.34 (0.42%)

09:25
03/02/18
03/02
09:25
03/02/18
09:25

Leerink pharmaceuticals analysts to hold an analyst/industry conference call

Analysts discuss Atopic Dermatitis and Lerrink's Dupixent Dermatitis Survey on an Analyst/Industry conference call to be held on March 2 at 10 am.

SNY

Sanofi

$39.19

(0.00%)

REGN

Regeneron

$321.78

1.34 (0.42%)

  • 02

    Mar

  • 02

    Mar

  • 08

    Mar

  • 25

    Mar

  • 02

    May

SNY Sanofi
$39.19

(0.00%)

02/26/18
LEER
02/26/18
NO CHANGE
LEER
Leerink remains positive on Regeneron/Sanofi Dupixent
Leerink analyst Geoffrey Porges says sentiment about the revenue potential of Regeneron (REGN)/Sanofi's (SNY) Dupixent has been declining over the past year, despite an impressive launch, and a steady flow of data for new indications and populations. The analyst remains positive about the product, forecasting 2020 revenue of $4B and growing to $6.5B by 2022 and $7.8B by 2025 from multiple indications.
02/19/18
JEFF
02/19/18
NO CHANGE
Target $145
JEFF
Buy
AnaptysBio price target raised to $145 from $101 at Jefferies
Jefferies analyst Biren Amin raised his price target for AnaptysBio (ANAB) to $145 after the company presented final data from its Phase IIa trial of ANB020 in 12 mod-to-severe adult atopic dermatitis patients. The shares closed Friday up $6.59, of 5.5%, to $126.45. Sustained efficacy on a single dose of '020 was seen up to day 78 at EASI-50 in 75% of patients, comparable to Phase II data from Sanofi (SNY) and Regeneron (REGN) competitor Dupixent, Amin tells investors in a research note. ANB020 beats if you account for single dose versus Q2 weeks of Dupi, the analyst contends. He keeps a Buy rating on AnaptysBio.
02/08/18
BERN
02/08/18
NO CHANGE
Target $45
BERN
Market Perform
Sanofi price target lowered to $45 from $50 at Bernstein
Bernstein analyst Tim Anderson lowered his price target for Sanofi to $45 from $50 following a "weak" quarter. The analyst reiterates a Market Perform rating on the shares.
01/24/18
ARGS
01/24/18
DOWNGRADE
ARGS
Hold
Bioverativ downgraded to Hold from Buy at Argus
Argus analyst Jasper Hellweg downgraded Bioverativ (BIVV) to Hold from Buy after the company announced a deal to be acquired by Sanofi (SNY) for $105 per share in cash. Hellweg says the strong run-up in the stock and the forthcoming acquisition have fully valued the stock at current levels.
REGN Regeneron
$321.78

1.34 (0.42%)

02/21/18
02/21/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Capital One (COF) downgraded to Neutral from Buy at Nomura Instinet with analyst Bill Carcache saying he believes the benefit of improving credit is now fully discounted in the shares and he sees "little room" for positive earnings revisions given the company's slowing sales growth. 2. Lionsgate (LGF.A, LGF.B) downgraded to Market Perform from Outperform at Bernstein with analyst Todd Juenger saying he believes competitive investment from rival premium and SVOD services has gotten much more intense, and notes that increased programming investment at Starz is a necessary but recurring cost of doing business, which means the normalized growth rate for Starz has to be lower. 3. Match Group (MTCH) downgraded to Neutral from Overweight at JPMorgan with analyst Doug Anmuth saying he sees fewer catalysts in the first half of 2018 now that the surge in Tinder Gold has passed. 4. BHP Billiton (BHP) downgraded to Neutral from Buy at Citi with analyst Heath Jansen saying the company's first half of fiscal 2018 results were below expectations. 5. Regeneron (REGN) downgraded to Hold from Buy at Canaccord with analyst John Newman citing concern over the company's decision to not provide guidance for Eylea, which is concerning because it will remain the company's core revenue component for many years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/21/18
ADAM
02/21/18
DOWNGRADE
Target $356
ADAM
Hold
Regeneron downgraded to Hold at Canaccord
As reported previously, Canaccord analyst John Newman downgraded Regeneron to Hold from Buy. The analyst cited concern over the company's decision to not provide guidance for Eylea, which is concerning because it will remain the company's core revenue component for many years. He also noted increasing competition for Dupixent ahead of the expected pediatric market uptick on 2021. Newman lowered his price target to $356 from $522 on Regeneron shares.
02/21/18
ADAM
02/21/18
DOWNGRADE
ADAM
Hold
Regeneron downgraded to Hold from Buy at Canaccord

TODAY'S FREE FLY STORIES

NFLX

Netflix

$400.24

4.32 (1.09%)

18:09
07/16/18
07/16
18:09
07/16/18
18:09
Hot Stocks
Netflix says sub additions were slower across all markets, not in any one market »

Total addressable market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

MU

Micron

$56.14

-0.22 (-0.39%)

, INTC

Intel

$52.02

-0.21 (-0.40%)

17:59
07/16/18
07/16
17:59
07/16/18
17:59
Hot Stocks
Micron and Intel announce update to 3D XPoint joint development program »

Micron (MU) and Intel…

MU

Micron

$56.14

-0.22 (-0.39%)

INTC

Intel

$52.02

-0.21 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,822.02

9.02 (0.50%)

17:59
07/16/18
07/16
17:59
07/16/18
17:59
Periodicals
Amazon Web Services experiences errors amid Prime Day snag, CNBC says »

After customers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 16

    Aug

PZZA

Papa John's

$51.43

-2.04 (-3.82%)

17:41
07/16/18
07/16
17:41
07/16/18
17:41
Periodicals
Papa John's founder regrets stepping down as chairman, Bloomberg says »

Papa John's founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GLD

SPDR Gold Trust

$117.55

-0.045 (-0.04%)

17:36
07/16/18
07/16
17:36
07/16/18
17:36
Hot Stocks
SPDR Gold Trust holdings fall to 794.01MT from 795.19MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$51.87

-1.06 (-2.00%)

17:29
07/16/18
07/16
17:29
07/16/18
17:29
Hot Stocks
Maxar's MDA acquires Neptec Design Group for C$42M »

MDA, a Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$136.21

-0.99 (-0.72%)

17:29
07/16/18
07/16
17:29
07/16/18
17:29
Syndicate
Breaking Syndicate news story on Autodesk »

Autodesk files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$58.83

-0.18 (-0.31%)

17:28
07/16/18
07/16
17:28
07/16/18
17:28
Hot Stocks
Showtime: Cohen did not present self as disabled veteran in 'Who is America?' »

CBS' Showtime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 09

    Aug

  • 06

    Sep

KTOV

Kitov Pharmaceuticals

$2.22

-0.13 (-5.53%)

17:27
07/16/18
07/16
17:27
07/16/18
17:27
Syndicate
Kitov Pharmaceuticals files to sell 2.56M American Depositary Shares »

Each representing 20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,822.02

9.02 (0.50%)

17:22
07/16/18
07/16
17:22
07/16/18
17:22
Hot Stocks
Amazon says 'some customers are having difficulty shopping' on Prime Day »

In a posting to its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 16

    Aug

FAF

First American

$51.89

0.02 (0.04%)

, FNF

Fidelity National

$37.23

0.14 (0.38%)

17:21
07/16/18
07/16
17:21
07/16/18
17:21
Upgrade
First American, Fidelity National rating change  »

First American upgraded…

FAF

First American

$51.89

0.02 (0.04%)

FNF

Fidelity National

$37.23

0.14 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

NAKD

Naked Brand Group

$4.95

-0.15 (-2.94%)

17:20
07/16/18
07/16
17:20
07/16/18
17:20
Syndicate
Breaking Syndicate news story on Naked Brand Group »

Naked Brand Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNF

Fidelity National

$37.23

0.14 (0.38%)

17:20
07/16/18
07/16
17:20
07/16/18
17:20
Upgrade
Fidelity National rating change  »

Fidelity National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

LMT

Lockheed Martin

$319.13

0.69 (0.22%)

17:20
07/16/18
07/16
17:20
07/16/18
17:20
Hot Stocks
Lockheed Martin awarded $450.7M U.S. Navy contract modification »

Lockheed Martin awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

FDEF

First Defiance Financial

$33.61

1.005 (3.08%)

17:18
07/16/18
07/16
17:18
07/16/18
17:18
Earnings
First Defiance Financial reports Q2 adjusted EPS 54c, consensus 52c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 31

    Jul

LNT

Alliant Energy

$42.79

-0.14 (-0.33%)

17:05
07/16/18
07/16
17:05
07/16/18
17:05
Hot Stocks
Alliant Energy announces 210MW wind farm in Iowa »

Iowa customers and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

TRQ

Turquoise Hill

$2.94

0.11 (3.89%)

17:02
07/16/18
07/16
17:02
07/16/18
17:02
Hot Stocks
Turquoise Hill reports Q2 throughput production up 6.3% from Q1 »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVEO

Aveo Pharmaceuticals

$2.85

-0.055 (-1.90%)

17:02
07/16/18
07/16
17:02
07/16/18
17:02
Syndicate
Breaking Syndicate news story on Aveo Pharmaceuticals »

Aveo Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
07/16/18
07/16
16:55
07/16/18
16:55
Conference/Events
Morgan Stanleey econo »

Australian Economist…

RIG

Transocean

$13.10

-0.37 (-2.75%)

16:42
07/16/18
07/16
16:42
07/16/18
16:42
Hot Stocks
Transocean announces $75M 13-well contract for Transocean 712 »

Transocean announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

AG

First Majestic

$7.44

-0.265 (-3.44%)

16:40
07/16/18
07/16
16:40
07/16/18
16:40
Hot Stocks
First Majestic raises 2018 CapEx view to $148.7M from $125.4M »

First Majestic has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALLY

Ally Financial

$27.24

-0.09 (-0.33%)

16:39
07/16/18
07/16
16:39
07/16/18
16:39
Hot Stocks
Ally Financial raises quarterly dividend to 15c from 13c per share »

Payable on August 15 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

OSG

Overseas Shipholding

$3.51

-0.125 (-3.44%)

16:38
07/16/18
07/16
16:38
07/16/18
16:38
Hot Stocks
Overseas Shipholding signs contract with HMD for two chemical tankers »

Overseas Shipholding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AG

First Majestic

$7.44

-0.265 (-3.44%)

16:38
07/16/18
07/16
16:38
07/16/18
16:38
Hot Stocks
First Majestic reports Q2 production 5.1M Ag eq oz., raises 2018 guidance »

First Majestic reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHDN

Churchill Downs

$303.50

0.05 (0.02%)

16:35
07/16/18
07/16
16:35
07/16/18
16:35
Hot Stocks
Churchill Downs to acquire remaining 50% ownership of Ocean Downs »

Churchill Downs, or CDI,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.